Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study: Rationale and Design.

Notwithstanding the dramatic improvement associated with Tafamidis in Heart Failure due to wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), the effect of exercise training on ATTRwt-CA remains unexplored. We hereby present rationale and design of the Exercise training and Rehabilitation in Cardiac Amyloidosis study. This interventional, controlled study will randomize ATTRwt-CA patients into a control group and a training group. Primary endpoint will be the distance obtained at the 6-min walk test. Quality-of-life, peak oxygen consumption, left and right heart architecture and function, and natriuretic peptides will be secondary endpoints.

Copyright © 2024 Elsevier Inc. All rights reserved.

Overview publication

TitleExercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study: Rationale and Design.
Date2024-07-01
Issue nameHeart failure clinics
Issue numberv20.3S:e55-e62
DOI10.1016/j.hfc.2024.09.008
PubMed40082016
AuthorsMarra AM, Palmiero G, Losi M, Mallardo M, Galati A, Bossone E, Esposito G, Calabrò P, Cittadini A & Limongelli G
InfoERICA Investigators, Crisci G, Monda E, Esposito G, Verrillo F, De Mare A, Dongiglio F, Ventura DD, Misserafiti B, Caruso R, Gabriele M, Palermo P
KeywordsCardiac amyloidosis, Cardiomyopathies, Exercise training, Heart failure, Rehabilitation, Wild-type transthyretin
Read Read publication